Investorideas podcasts on iTunes, Google Play Music and potcasts - cannabis news and stocks to watch plus insight from thought leaders and experts crypto corner    Play by Play – the latest sports headlines and sports stock news    420 Cannabis Investor Ideas Call us 800 665 0411


Join our smart investors - Get the best stock directories in  blockchain, cannabis, crypto, AI, IoT, cleantech. Daily podcasts in cannabis and crpto. Just $99  a year

Today's Viridian #Cannabis Deal Tracker for Week Ended October 20, 2017

Viridian Capital Advisors (


October 25, 2017 ( Newswire) Viridian Capital Advisors, LLC reports on its weekly Viridian Activity in the Cannabis Industry for the week ending October 20, 2017.

Capital Raises

Mergers & Acquisitions

Summary of Year-to-Date Transactions

Capital Raises

Mergers & Acquisitions

Announcements for Week Ended October 20, 2017

Capital Raises

Agriculture Technology
Indoor Harvest Announces $2 Million Fixed Funding Commitment

Calyx to Complete Non-Brokered Private Placement

Consumption Devices
The Blinc Group Successfully Closes First Financing Round

Cultivation & Retail
Emblem Announces C$25 Million Bought Deal

Emblem Announces Increase in Bought Deal Offering to C$12 Million

Aurora Cannabis Announces C$6 Million Private Placement

Aphria Inc. Announces C$80 Million Bought Deal

Supreme Pharmaceuticals Announces C$30 Million Bought Deal Private Placement of Convertible Debenture Units

Supreme Pharmaceuticals Announces Upsize of Previously Announced Bought Deal Private Placement to C$35 Million

Cannabis Wheaton Provides Initial Advance of C$5,000,000 to Beleave

THC Announces C$839,974 Financing

WeedMD Announces C$15 Million Bought Deal Private Placement of Convertible Debentures

Valens GroWorks Announces Exercise of Warrants

Infused Products & Extracts
Plus Receives $2M Series A for Cannabis-Infused Products

Healthcare Investment Funds Set Industry-Breaking Commitment to Cannabis Sector

Cronos Group Inc. Announces C$15 Million Bought Deal

Abattis Announces Private Placement for Proceeds of up to C$4 Million

Reliq Health Technologies Announces Upsize of Previously Announced Private Placement Financing to C$5.0 Million

Glance Announces Over-Allotment for Over-Subscription

Mergers & Acquisitions

Agriculture Technology
Future Farm Signs Definitive Agreement to Acquire 120-Acre Licensed Industrial Hemp Farm

Consumption Devices
Wee-Cig Acquires 100% of WeeMed America Management Ltd.

Cultivation & Retail
Terra Health Network Inc. Purchases Assets to Grow its Patient Navigation Business

Infused Products & Extracts
Pivot Pharma Executes Binding Letter of Intent to Acquire ACI Foods Inc.

Quinsam Capital Corporation Completes Acquisition of High Standard Royalty Corp.

Marapharm Ventures Inc. Announces That It Has Purchased an Additional 1.5 Million Units of Veritas Pharma Inc.

SinglePoint Completes Acquisition of Profitable Denver Colorado-Based Company

Capital Raise and M&A Transaction

Cultivation & Retail
Maricann Provides Update on Financing, NanoLeaf Acquisition and Other Matters

Naturally Splendid Acquires Prosnack Natural Foods Inc. and Closes Final Tranche for C$333,835

Quinsam Capital Corporation Completes Acquisition of High Standard Royalty Corp.

Going-Public Transactions

Agriculture Technology
Micron Waste Technologies Inc. Announces Completion of Acquisition

Miscellaneous Ancillary
mCig to Spin-Off Technology Division as a Stand-Alone Public Company

Joint Ventures

Cultivation & Retail
Easton Pharmaceuticals Announces Final Payment Completing C$1.3 Million JV Agreement with Alliance Group for a 50% Property Ownership Interest and Various Businesses Including the Cultivation of Medical / Recreational Marijuana for National Canadian Market

Infused Products & Extracts
Canada House is Pleased to Announce Its Joint Venture With Nutritional High, an Expert in Cannabis Oil Extracts and Edibles

New Cannabis Funds
Floris Capital Launches to Invest in Cannabis Related Companies

To Learn More About the Viridian Cannabis Deal Tracker, Contact:

Harrison Phillips
Viridian Capital Advisors, LLC
(212) 209-3086


The information contained herein is for informational purposes and is not intended as a research report. It should not be construed as Viridian recommending investment in cannabis companies or as a solicitation to buy or sell any security or engage in a particular investment strategy. Investment in cannabis companies entails substantial risk. Before acting on any information, you should consider whether it is suitable for your particular circumstances and consult all available material, and, if necessary, seek professional advice.

Viridian Capital Advisors and its affiliates, as well as their respective partners, directors, shareholders, and employees, may have a position in the securities mentioned herein or may make purchases and/or sales from time to time. Viridian Capital Advisors, through broker-dealer services provided by Pickwick Capital Partners, LLC, (Member FINRA/SIPC), may act, or may have acted in the past, as a financial advisor to certain companies mentioned herein and may receive, or may have received, a remuneration for their services from those companies.

About the Viridian Cannabis Deal Tracker

The Viridian Cannabis Deal Tracker monitors capital raise, mergers & acquisition, joint venture, and licensing activity for both public and private companies in the legal cannabis industry across 12 key sectors, including Agriculture Technology, Biotech/Pharma, Consulting Services, Consumption Devices, Cultivation & Retail, Hemp, Investments/M&Amp;Amp;Amp;A (Holding Companies), Infused Products & Extracts, Miscellaneous Ancillary, Physical Security, Real Estate, and Software/Media.

Integrating more than 3 years of data collection, segmentation, and analysis, the Viridian Cannabis Deal Tracker supports decision-making by providing sector-specific actionable intelligence and trend analysis in regard to issuers, investors, acquirers, valuations, deal structures, and deal terms.

The above information whether in part or in its entirety neither constitutes an offer nor makes any recommendation to buy or sell any securities.

About Viridian Capital Advisors, LLC

Viridian Capital Advisors ( is a financial and strategic advisory firm dedicated to the cannabis market. We are a data- and market intelligence-driven firm that provides investment banking, M&Amp;Amp;Amp;A, corporate development, and investor relations services to emerging growth companies and qualified investors in the cannabis sector. Our banking practice, through broker-dealer Pickwick Capital Partners, LLC (Member FINRA/SIPC), provides capital and M&Amp;Amp;Amp;A to fund the growth of our clients, while our advisory practice helps to position and build their businesses. Our team’s decades of high level operating and transactional experience on Wall Street in a variety of emerging sectors, allows Viridian to provide comprehensive strategic and financial solutions that assist cannabis enterprises in realizing their full potential.

Marijuana remains illegal under federal law. The Federal Government does not recognize marijuana to have any medicinal values. Marijuana cultivation, possession, consumption, sales, and distribution are illegal under federal laws and also certain state laws. Please note that there are differences in marijuana laws from one state, county, or city to another.

Marijuana / Hemp Stocks

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

More Info: Newswire

This news is published on the Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: Learn more about publishing your news release on the newswire

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: Global investors must adhere to regulations of each country.

Please read privacy policy: